Keywords: celera, sells, cathepsin, program, schering, usa-based, drugmaker

Celera sells Cathepsin program to Schering

Article | 03 July 2006

Print This

USA-based drugmaker Celera Genomics, which is owned by Applera, says that Germany's Schering AG has acquired its cathepsin S inhibitor ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in